Logo

Emcure Pharmaceuticals Ltd. Share Price

Pharmaceuticals & Drugs

Emcure Pharmaceuticals Ltd. (INR)1029.7-43.5   (-4.1%)

Exchange ScripsBSE544210NSEEMCUREISININE168P01015

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Emcure Pharmaceuticals Ltd. Performance

Market performance

Open price1060
High1080
Volumes49941
Prev Close1029.7
Low1024
Closing date2025-04-25

Historical performance

1 Year High1580.00
3 Year High1580.00
5 Year High1580.00
1 Year Low889.00
3 Year Low889.00
5 Year Low889.00

Emcure Pharmaceuticals Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
19490
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
37.44
Dividend Yield
Dividend Yield
0.03 %

Emcure Pharmaceuticals Ltd. Investment Returns

1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Emcure Pharmaceuticals Ltd. Technicals

IndicatorsValueSignal
5-DMA1071.06Bearish
10-DMA1023.93Bullish
20-DMA1021.24Bullish
50-DMA1007.05Bullish
100-DMA1183Bearish
200-DMA

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024
Promoters202020
Foreign Investors222
Domestic Investors181818
Public Investors139651143429152894
Government---------

Emcure Pharmaceuticals Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income570459635354
Operating Profit12867122711393412674
Interest2371213617601981
Depreciation3124260124493233
Profit Before Tax7272747297256573
Consolidated Net Profit4982532066223921
Adjusted EPS28293722

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1812180918091809
Total Reserves27566230541790820804
Minority Interest169514851266950
Total Non-Current Liabilities13771904686848829
Total Liabilities77094657345947466591
Capital Work in Progress1323403530982216
Total Assets77094657345947466591

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities10972746976827044
Cash Flow from Investing Activities-7125-4677-7888-2518
Cash Flow from Financing Activitie-1642-1454-1519-1889
Net Cash Inflow / Outflow22051338-17242637
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 37.44.
  • 3Y Stock Price CAGR of the stock is None.
  • The stock has a beta of 1.3.
  • In the last financial year, the company had an EBITDA of ₹12867 Million.
  • The company generated revenue of ₹66583 Million in the previous financial year.

Emcure Pharmaceuticals Ltd.

1029.7-43.5   (-4.1%)

Investment Amount: ₹ 1000000
Current Value: ₹ 757605.9
No. of Shares: 735.8
Performance:-24.2%
P/L: ₹-242394.1

Top Gainers

SymbolChange%
LFIC203.61(20%)
CARRARO386.55(17%)
MANAKSTEEL73.32(15%)
BUTTERFLY700.45(15%)
COUNCODOS10.84(10%)

Top Losers

SymbolChange%
SRM321.35(-11%)
BHANDARI4.85(-11%)
MINDTECK208.55(-10%)
OSWALAGRO87.03(-9%)
PVP25.67(-9%)
AMDIND46.95(-9%)
MAGNUM27.9(-9%)
PAVNAIND322.75(-8%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

52.3

55.87

March 26 - April 26

Hester Biosciences Ltd.

40.9

1940.5

March 26 - April 26

SMS Lifesciences India Ltd.

33.7

1448.9

March 26 - April 26

Sakar Healthcare Ltd.

27.8

291.03

March 26 - April 26

Natural Capsules Ltd.

27.1

216.37

March 26 - April 26

Brooks Laboratories Ltd.

25.1

139.83

March 26 - April 26

Valiant Laboratories Ltd.

21.6

99.25

March 26 - April 26

Panacea Biotec Ltd.

20.7

520.8

March 26 - April 26

Announcing Stock of the Month!

Stock of the Month
Stock of the Month